Real-World Evidence
Generate fit-for-purpose evidence to support clinical, regulatory and access decisions.
Evidence strategy · Oncology · Ageing
We start with the questions that matter.
Real-world evidence, clinical trials and strategic advisory to optimize the use of cancer medicines in older adults.
Older adults are a growing proportion of people living with cancer, yet important evidence gaps remain across clinical development and real-world practice. OmegaOnco brings together scientific expertise, real-world evidence and AI-enabled intelligence to address the questions that matter for older patients.
A focused set of capabilities spanning evidence generation, clinical research, strategic advisory and AI-enabled analysis.
Generate fit-for-purpose evidence to support clinical, regulatory and access decisions.
Strengthen evidence generation for older adults across real-world and hybrid research settings.
Align evidence, development and lifecycle strategy around the questions that matter.
Use fit-for-purpose AI-enabled approaches, with expert oversight, to turn complex oncology data into faster, decision-ready evidence.
Talk to OmegaOnco about an evidence need in older adults with cancer.